Skip to main content
logo
Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.26
-0.14 (-1.23%)
Oct 1, 2026, 4:00 PM EDT - Market closed

Keros Therapeutics Revenue

Keros Therapeutics had revenue of $15.01M in the twelve months ending June 30, 2026, down -93.55% year-over-year. In the year 2025, Keros Therapeutics had annual revenue of $244.06M with 6,774.96% growth.

Revenue (ttm)
$15.01M
Revenue Growth
-93.55%
P/S Ratio
14.87
Revenue / Employee
$163,196
Employees
92
Market Cap
223.25M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025244.06M240.51M6,774.96%
Dec 31, 20243.55M3.40M2,250.99%
Dec 31, 2023151.00K--
Dec 31, 2022---
Dec 31, 202120.10M--
Dec 31, 2020---
Dec 31, 201910.00M--
Dec 31, 201810.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Protalix BioTherapeutics80.62M
Compugen74.00M
Foghorn Therapeutics36.74M
ProQR Therapeutics21.05M
Adagene9.29M
Whitehawk Therapeutics7.15M
Entrada Therapeutics4.69M
Cartesian Therapeutics1.48M
Revenue Rankings

KROS News

More News